Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Lynn Marie Pezzanite

TitleAsst Professor Adjoint
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-ORTHO General Operations

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cassano JM, Leonard BC, Martins BC, Vapniarsky N, Morgan JT, Dow SW, Wotman KL, Pezzanite LM. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis. Front Vet Sci. 2023; 10:1293199. PMID: 38162475.
      View in: PubMed
    2. Rockow M, Griffenhagen G, Landolt G, Hendrickson D, Pezzanite L. The Effects of Antimicrobial Protocols and Other Perioperative Factors on Postoperative Complications in Horses Undergoing Celiotomy: A Retrospective Analysis, 2008-2021. Animals (Basel). 2023 Nov 19; 13(22). PMID: 38003189.
      View in: PubMed
    3. Webster A, Pezzanite L, Hendrickson D, Griffenhagen G. Review of intra-articular local anaesthetic administration in horses: Clinical indications, cytotoxicity, and outcomes. Equine Vet J. 2023 Nov 08. PMID: 37940372.
      View in: PubMed
    4. Thampi P, Seabaugh KA, Pezzanite LM, Chu CR, Phillips JN, Grieger JC, McIlwraith CW, Samulski RJ, Goodrich LR. A pilot study to determine the optimal dose of scAAVIL-1ra in a large animal model of post-traumatic osteoarthritis. Gene Ther. 2023 Dec; 30(12):792-800. PMID: 37696981.
      View in: PubMed
    5. Pezzanite LM, Chow L, Dow SW, Goodrich LR, Gilbertie JM, Schnabel LV. Antimicrobial Properties of Equine Stromal Cells and Platelets and Future Directions. Vet Clin North Am Equine Pract. 2023 Dec; 39(3):565-578. PMID: 37442729.
      View in: PubMed
    6. Pezzanite LM, Timkovich AE, Sikes KJ, Chow L, Hendrickson DA, Becker JR, Webster A, Santangelo KS, Dow S. Erythrocyte removal from bone marrow aspirate concentrate improves efficacy as intra-articular cellular therapy in a rodent osteoarthritis model. Ann Transl Med. 2023 Jun 30; 11(9):311. PMID: 37404993.
      View in: PubMed
    7. Rockow M, Griffenhagen G, Landolt G, Hendrickson D, Pezzanite L. Current Antimicrobial Use in Horses Undergoing Exploratory Celiotomy: A Survey of Board-Certified Equine Specialists. Animals (Basel). 2023 Apr 22; 13(9). PMID: 37174470.
      View in: PubMed
    8. Kawahisa-Piquini G, Bass L, Pezzanite LM, Moorman VJ. Hoof Unevenness in Juvenile Quarter Horses During First 6 Months of Training. J Equine Vet Sci. 2023 07; 126:104494. PMID: 37075868.
      View in: PubMed
    9. O'Brien TJ, Pezzanite LM, Acutt EV, Vilander AC, Hassel DM, Hector RC, Hendrickson DA. Successful surgical removal of a pheochromocytoma in a mare via trans-costal approach. Equine Vet J. 2023 Nov; 55(6):1012-1020. PMID: 36754850.
      View in: PubMed
    10. Pezzanite LM, Chow L, Griffenhagen GM, Bass L, Goodrich LR, Impastato R, Dow S. Distinct differences in immunological properties of equine orthobiologics revealed by functional and transcriptomic analysis using an activated macrophage readout system. Front Vet Sci. 2023; 10:1109473. PMID: 36876001.
      View in: PubMed
    11. Kawahisa-Piquini G, Bass LD, Pezzanite LM, Moorman VJ. Effect of age at training initiation on hoof morphology and lameness in juvenile American Quarter Horses. Equine Vet J. 2023 Sep; 55(5):765-776. PMID: 36572927.
      View in: PubMed
    12. Pezzanite LM, Griffenhagen GM, Bass L, Okudaira M, Larson B, Hendrickson DA. Liposomal bupivacaine is both safe and effective when administered via local infiltration at surgical site and mesovarium for laparoscopic ovariectomy in mares. Equine Vet J. 2023 Sep; 55(5):755-764. PMID: 36572902.
      View in: PubMed
    13. Wotman KL, Chow L, Martabano B, Pezzanite LM, Dow S. Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia. Cancer Immunol Immunother. 2023 May; 72(5):1185-1198. PMID: 36367558.
      View in: PubMed
    14. Pezzanite LM, Chow L, Strumpf A, Johnson V, Dow SW. Immune Activated Cellular Therapy for Drug Resistant Infections: Rationale, Mechanisms, and Implications for Veterinary Medicine. Vet Sci. 2022 Nov 04; 9(11). PMID: 36356087.
      View in: PubMed
    15. Pezzanite LM, Chow L, Phillips J, Griffenhagen GM, Moore AR, Schaer TP, Engiles JB, Werpy N, Gilbertie J, Schnabel LV, Antczak D, Miller D, Dow S, Goodrich LR. TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant Staphylococcal septic arthritis in an equine model. Ann Transl Med. 2022 Nov; 10(21):1157. PMID: 36467344.
      View in: PubMed
    16. Afzali MF, Pannone SC, Martinez RB, Campbell MA, Sanford JL, Pezzanite LM, Kurihara J, Johnson V, Dow SW, Santangelo KS. Intravenous injection of adipose-derived mesenchymal stromal cells benefits gait and inflammation in a spontaneous osteoarthritis model. J Orthop Res. 2023 04; 41(4):902-912. PMID: 36030381.
      View in: PubMed
    17. Daniels A, Pezzanite LM, Griffenhagen GM, Hendrickson DA. Evaluation of factors associated with surgical site infection in equine proximal interphalangeal joint arthrodesis: 54 cases (2010-2019). Vet Med Sci. 2022 07; 8(4):1478-1488. PMID: 35594487.
      View in: PubMed
    18. Moorman VJ, Pezzanite LM, Griffenhagen GM. Liposomal bupivacaine provides longer duration analgesia than bupivacaine hydrochloride in an adjustable sole-pressure model of equine lameness. Am J Vet Res. 2022 Jan 28; 83(4):298-304. PMID: 35092669.
      View in: PubMed
    19. Estrada McDermott J, Pezzanite L, Goodrich L, Santangelo K, Chow L, Dow S, Wheat W. Role of Innate Immunity in Initiation and Progression of Osteoarthritis, with Emphasis on Horses. Animals (Basel). 2021 Nov 13; 11(11). PMID: 34827979.
      View in: PubMed
    20. Pezzanite LM, Hendrickson DA, Dow S, Stoneback J, Chow L, Krause D, Goodrich L. Intra-articular administration of antibiotics in horses: Justifications, risks, reconsideration of use and outcomes. Equine Vet J. 2022 Jan; 54(1):24-38. PMID: 34459027.
      View in: PubMed
    21. Pezzanite LM, Hackett ES, McCready E, Easley JT. Outcomes following single, caudally based bilateral versus unilateral frontonasal sinusotomy for treatment of equine paranasal sinus disease. Vet Med Sci. 2021 11; 7(6):2209-2218. PMID: 34405566.
      View in: PubMed
    22. Krause DM, Pezzanite LM, Griffenhagen GM, Hendrickson DA. Comparison of equine synovial sepsis rate following intrasynovial injection in ambulatory versus hospital settings. Equine Vet J. 2022 May; 54(3):523-530. PMID: 34115426.
      View in: PubMed
    23. Pezzanite L, Chow L, Hendrickson D, Gustafson DL, Russell Moore A, Stoneback J, Griffenhagen GM, Piquini G, Phillips J, Lunghofer P, Dow S, Goodrich LR. Evaluation of Intra-Articular Amikacin Administration in an Equine Non-inflammatory Joint Model to Identify Effective Bactericidal Concentrations While Minimizing Cytotoxicity. Front Vet Sci. 2021; 8:676774. PMID: 34095281.
      View in: PubMed
    24. Pezzanite LM, Easley JT, Bayless R, Aldrich E, Nelson BB, Seim HB, Nout-Lomas YS. Outcomes after cervical vertebral interbody fusion using an interbody fusion device and polyaxial pedicle screw and rod construct in 10 horses (2015-2019). Equine Vet J. 2022 Mar; 54(2):347-358. PMID: 33844334.
      View in: PubMed
    25. Pezzanite L, Chow L, Griffenhagen G, Dow S, Goodrich L. Impact of Three Different Serum Sources on Functional Properties of Equine Mesenchymal Stromal Cells. Front Vet Sci. 2021; 8:634064. PMID: 33996964.
      View in: PubMed
    26. Pezzanite LM, Chow L, Johnson V, Griffenhagen GM, Goodrich L, Dow S. Toll-like receptor activation of equine mesenchymal stromal cells to enhance antibacterial activity and immunomodulatory cytokine secretion. Vet Surg. 2021 May; 50(4):858-871. PMID: 33797775.
      View in: PubMed
    27. Newman RJ, Chow L, Goodrich LR, Lambrechts NE, Dow SW, Pezzanite LM. Susceptibility of canine chondrocytes and synoviocytes to antibiotic cytotoxicity in vitro. Vet Surg. 2021 Apr; 50(3):650-658. PMID: 33606293.
      View in: PubMed
    28. Pezzanite LM, Griffenhagen GM, Krause DM, Hendrickson DA. Retrospective evaluation of association between perioperative antimicrobial protocol and complications following elective equine synovial endoscopy. Vet Med Sci. 2021 05; 7(3):609-620. PMID: 33595201.
      View in: PubMed
    29. Pezzanite L, Chow L, Piquini G, Griffenhagen G, Ramirez D, Dow S, Goodrich L. Use of in vitro assays to identify antibiotics that are cytotoxic to normal equine chondrocytes and synovial cells. Equine Vet J. 2021 May; 53(3):579-589. PMID: 32544273.
      View in: PubMed
    30. Pezzanite L, Chow L, Soontararak S, Phillips J, Goodrich L, Dow S. Amikacin induces rapid dose-dependent apoptotic cell death in equine chondrocytes and synovial cells in vitro. Equine Vet J. 2020 Sep; 52(5):715-724. PMID: 31997397.
      View in: PubMed
    31. Pezzanite L, Easley J. Update on Surgical Treatment of Wobblers. Vet Clin North Am Equine Pract. 2019 Aug; 35(2):299-309. PMID: 31147149.
      View in: PubMed
    32. Pezzanite L, Bass L, Kawcak C, Goodrich L, Moorman V. The relationship between sagittal hoof conformation and hindlimb lameness in the horse. Equine Vet J. 2019 Jul; 51(4):464-469. PMID: 30472759.
      View in: PubMed
    33. Pezzanite LM, Hackett ES. Technique-associated outcomes in horses following large colon resection. Vet Surg. 2017 Nov; 46(8):1061-1067. PMID: 28987065.
      View in: PubMed
    34. Pezzanite LM, Fortier LA, Antczak DF, Cassano JM, Brosnahan MM, Miller D, Schnabel LV. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo. Stem Cell Res Ther. 2015 Apr 12; 6:54. PMID: 25889095.
      View in: PubMed
    35. Schnabel LV, Pezzanite LM, Antczak DF, Felippe MJ, Fortier LA. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro. Stem Cell Res Ther. 2014 Jan 24; 5(1):13. PMID: 24461709.
      View in: PubMed
    Pezzanite's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (97) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)